A detailed history of Clean Yield Group transactions in United Therapeutics Corp stock. As of the latest transaction made, Clean Yield Group holds 300 shares of UTHR stock, worth $108,066. This represents 0.04% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$108,066
Previous $95,000 12.63%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021

BUY
$179.86 - $214.88 $26,979 - $32,232
150 Added 100.0%
300 $55,000
Q2 2021

Jul 26, 2021

BUY
$170.47 - $211.93 $25,570 - $31,789
150 New
150 $27,000
Q1 2021

Apr 26, 2021

SELL
$153.94 - $174.85 $11,545 - $13,113
-75 Closed
0 $0
Q4 2020

Jan 26, 2021

BUY
$101.87 - $151.79 $7,640 - $11,384
75 New
75 $11,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.